Supported medical care: A multi-faceted approach to helping HIV/hepatitis C virus co-infected adults with serious mental illness

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Goldberg, Richard W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SCHOOL OF MEDICINE   (United States)

Author keywords

Case management; Hepatitis C; HIV; Skills training; Supported medical care

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; CHRONIC DISEASE; CLINICAL RESEARCH; COMORBIDITY; CONCEPT FORMATION; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MENTAL INSTABILITY; PATIENT CARE; PATIENT INFORMATION; PRIORITY JOURNAL; SKILL; SUPPORT GROUP;

EID: 27944507273     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192092.38883.22     Document Type: Article

References (35)

1. US Department of Health and Human Services. Mental health: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Health; 1999.
2. Osher F, Goldberg R, McNary S, Swartz M, Essock S, Butterfield M, Rosenberg S. Substance abuse and the transmission of hepatitis C among persons with severe mental illness. Psychiatr Serv 2003; 54:842-847.
3. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull 1996; 22:413-430.
4. Brown S. Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry 1997; 171:502-508.
5. Druss BG, Rosenheck RA. Mental disorders and access to medical care in the United States. Am J Psychiatry 1998; 155:1775-1777.
6. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental disorders and use of cardiovascular procedures after myocardial infarction. JAMA 2000; 283:506-511.
7. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163:183-189.
8. Rosenberg SD, Goodman LA, Osher FC, Swartz M, Essock S, Butterfield N, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health 2001; 91:31-37.
9. Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Memorial Fund Quarterly 1973; 51:95-124.
10. Dixon L, Wohlheiter K, Thompson D. Medical management of persons with schizophrenia. In: Comprehensive care of schizophrenia: a textbook of clinical management. Edited by Lieberman JA, Murray RM. London: Martin Dunitz; 2001. pp. 281-292.
11. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ, et al. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry 1996; 66:31-77.
12. Dickey B, Azeni H. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care. Am J Public Health 1996; 86:973-977.
13. Sulkowski MS, Thomas DL. Hepatitis C in the HIV-infected person. Ann Intern Med 2003; 138:197-207.
14. Druss BG, Rohrbaugh RM, Levinson CM, Rosenheck RA. Integrated medical care for patients with serious psychiatric illness: a randomized trial. Arch Gen Psychiatry 2001; 58:861-868.
15. Meyer J, Nasrallah H. Issues surrounding medical care for individuals with schizophrenia: the challenge of dual neglect by patients and the system. In: Meyer J, Nasrallah H, editors. Medical illness and schizophrenia. Arlington, VA: APPI Press; 2003. pp. 1-11.
16. Essock SM, Dowden S, Constantine NT, Katz L, Swartz MS, Meador KG, et al. Blood-borne infections and persons with mental illness: risk factors for HIV, hepatitis B, and hepatitis C among persons with severe mental illness. Psychiatric Serv 2003; 54:836-841.
17. Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis b, and hepatitis c among homeless persons with co-occurring mental illness and substance use disorders. Comp Psychiatry 2003; 44:293-302.
18. Goldberg RW. Hepatitis and HIV screening, education, and treatment for adults with serious mental illness. Gen Hosp Psychiatry 2004; 26:167-168.
19. Van Thiel DH, Friedlander L, Molloy PJ, Fagiuoli S, Kania RJ, Caraceni P. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness. Eur J Gastroenterol Hepatol 1995; 7:165-168.
20. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV anitvirals among persons with serious mental illness. AIDS Patient Care STD 2003; 17:179-186.
21. Andersen RM. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995; 36:1-10.
22. Bandura A. Self-efficacy mechanism and physiological activation and health promoting behavior. In: Neurobiology of learning, emotion and affect. Edited by Madden VL. New York: Raven; 1991. pp. 229-269.
23. ICDH-2. International classification of functioning and disability. Beta-2 draft. Short version. Geneva: World Health Organization; 1999.
24. National Institutes of Health. National Institutes of Health consensus development conference statement: management of hepatitis C: 2002. Hepatology 2002; 36(Suppl. 1): S3-S20.
25. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47(No. RR-T9):1-39.
26. Warsi A, Wang PS, LaValley MP, Avron J, Solomon DH. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. Arch Intern Med 2004; 164:1641-1649.
27. Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Counsel 2002; 48:177-187.
28. Marks R, Allegrante JP, Lorig K. A review and synthesis of research evidence for self-efficacy enhancing interventions for reducing chronic disability: implications for health education practice. Health Prom Pract 2005; 6:37-43.
29. Lorig KR, Stewart AL, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcomes measures for health education and other health care interventions. Thousand Oaks, CA: Sage Publications; 1996.
30. Stanford Patient Education Research Center. Chronic disease self-management leader's manual - revised. Palo Alto, CA: Stanford Patient Education Research Center; 1997.
31. Gifford AL, Laurent DD, Gonzales VM, Chesney MA, Lorig KR. Pilot randomized trial of education to improve self-management skills of men with symptomatic HIV/AIDs. J Acquir Immune Defic Syndr Human Retrovirol 1998; 18:136-144.
32. Lorig KR, Sobel DS, Stewart AL, Brown BW, Bandura A, Ritter P, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Med Care 1999; 37:5-14.
33. Bellack AS, Mueser KT, Gingerich S, Agresta J. Social skills training for schizophrenia. New York: Guildford; 1997.
34. Stanford Patient Education Research Center. Stanford University, Palo Alto, CA. Available at: http://patienteducation.stanford.edu. Accessed 09 August 2005.
35. Agency for Health Care Research and Quality. Put prevention in practice. Rockville, MD: Agency for Health Care Research and Quality; 2000. Available at: www.ahrq.gov/clinic/ppipix.htm. Accessed 09 August 2005.